Our research proved that luteolin restrained the proliferation of PASMCs and improved PAH at least partly through inhibiting Hippo-YAP/PI3K/AKT pathway, but whether luteolin inhibits the proliferation of PASMCs through signal pathways remains to be further studied. This evidence concerns the gene YAP1 and pulmonary arterial hypertension.